These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1138 related items for PubMed ID: 26009596

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care.
    Ramaswami U, Humphries SE, Priestley-Barnham L, Green P, Wald DS, Capps N, Anderson M, Dale P, Morris AA.
    Atherosclerosis; 2019 Nov; 290():1-8. PubMed ID: 31536851
    [Abstract] [Full Text] [Related]

  • 23. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK.
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Parent-child genetic testing for familial hypercholesterolaemia in an Australian context.
    Pang J, Martin AC, Bates TR, Hooper AJ, Bell DA, Burnett JR, Norman R, Watts GF.
    J Paediatr Child Health; 2018 Jul; 54(7):741-747. PubMed ID: 29626384
    [Abstract] [Full Text] [Related]

  • 26. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).
    Descamps OS, Van Caenegem O, Hermans MP, Balligand JL, Beauloye C, Bondue A, Carlier S, Castermans E, Chenot F, Claeys M, De Block C, de Leener A, De Meester A, Demeure F, De Raedt H, Desmet W, Elegeert I, Guillaume M, Hoffer E, Kacenelenbogen R, Lancellotti P, Langlois M, Leone A, Mertens A, Paquot N, Vanakker O, Vanoverschelde JL, Verhaegen A, Vermeersch P, Wallemacq C, Rietzschel E, Belgian Atherosclerosis Society/Belgian Lipid Club (BAS/BLC), the Belgian Society of Cardiology (BSC) and the Royal Belgian Society of Laboratory Medicine (RBSLM).
    Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022.
    Harada-Shiba M, Ohtake A, Sugiyama D, Tada H, Dobashi K, Matsuki K, Minamino T, Yamashita S, Yamamoto Y.
    J Atheroscler Thromb; 2023 May 01; 30(5):531-557. PubMed ID: 36682777
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey.
    Kose E, Kose M, Ozturk SI, Ozcan E, Onay H, Ozkan B.
    J Pediatr Endocrinol Metab; 2020 Aug 24; 33(10):1251-1256. PubMed ID: 32829317
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia.
    Descamps OS, Gilbeau JP, Leysen X, Van Leuven F, Heller FR.
    Eur J Clin Invest; 2001 Nov 24; 31(11):958-65. PubMed ID: 11737238
    [Abstract] [Full Text] [Related]

  • 33. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
    Miltiadous G, Xenophontos S, Bairaktari E, Ganotakis M, Cariolou M, Elisaf M.
    Pharmacogenet Genomics; 2005 Apr 24; 15(4):219-25. PubMed ID: 15864114
    [Abstract] [Full Text] [Related]

  • 34. Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans.
    Thompson GR.
    Atherosclerosis; 2018 Sep 24; 276():148-154. PubMed ID: 30064057
    [Abstract] [Full Text] [Related]

  • 35. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P, Gentile M, Marotta G, Iannuzzi A, Sodano M, De Simone B, Jossa F, Iannuzzo G, Giacobbe C, Di Taranto MD, Fortunato G.
    Eur J Prev Cardiol; 2017 Jul 24; 24(10):1051-1059. PubMed ID: 28353356
    [Abstract] [Full Text] [Related]

  • 36. Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.
    Rodríguez-Borjabad C, Ibarretxe D, Girona J, Ferré R, Feliu A, Amigó N, Guijarro E, Masana L, Plana N, DECOPIN Group.
    Atherosclerosis; 2018 Mar 24; 270():117-122. PubMed ID: 29407879
    [Abstract] [Full Text] [Related]

  • 37. Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National Database.
    Sonmez A, Demirci I, Haymana C, Tasci I, Ayvalı MO, Ata N, Ezgu FS, Bayram F, Barcin C, Caglayan M, Ülgü MM, Birinci S, Tokgozoglu L, Satman I, Kayikcioglu M.
    Atherosclerosis; 2023 Jun 24; 375():9-20. PubMed ID: 37216728
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.
    Zafrir B, Shapira C, Lavie G, Halon DA, Flugelman MY.
    J Clin Lipidol; 2016 Jun 24; 10(6):1338-1343. PubMed ID: 27919350
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.